Home  >  Products  >  ATCAY (ataxia, cerebellar, Cayman type ) Blocking Peptide (the C terminal of ATCAY)(100ug)
ATCAY (ataxia, cerebellar, Cayman type ) Blocking Peptide (the C terminal of ATCAY)(100ug)

ATCAY (ataxia, cerebellar, Cayman type ) Blocking Peptide (the C terminal of ATCAY)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ATCAY Antibody (ARP60864_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60864
Size: 100ug
Weight: 42kDa
Gene: 85300
Format: Lyophilized powder
Target: This gene encodes a neuron-restricted protein that contains a CRAL-TRIO motif common to proteins that bind small lipophilic molecules. Mutations in this gene are associated with cerebellar ataxia, Cayman type.
Alternative names: BNIP-H; CLAC; KIAA1872
See Full Product Listings >